Kimia Biosciences Balance Sheet Health
Financial Health criteria checks 3/6
Kimia Biosciences has a total shareholder equity of ₹3.3M and total debt of ₹495.1M, which brings its debt-to-equity ratio to 14959%. Its total assets and total liabilities are ₹999.7M and ₹996.4M respectively. Kimia Biosciences's EBIT is ₹15.0M making its interest coverage ratio 0.3. It has cash and short-term investments of ₹5.3M.
Key information
14,959.0%
Debt to equity ratio
₹495.14m
Debt
| Interest coverage ratio | 0.3x |
| Cash | ₹5.34m |
| Equity | ₹3.31m |
| Total liabilities | ₹996.36m |
| Total assets | ₹999.67m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 530313's short term assets (₹614.1M) do not cover its short term liabilities (₹694.4M).
Long Term Liabilities: 530313's short term assets (₹614.1M) exceed its long term liabilities (₹302.0M).
Debt to Equity History and Analysis
Debt Level: 530313's net debt to equity ratio (14797.5%) is considered high.
Reducing Debt: 530313's debt to equity ratio has increased from 483.5% to 14959% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Whilst unprofitable 530313 has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.
Forecast Cash Runway: 530313 is unprofitable but has sufficient cash runway for more than 3 years, due to free cash flow being positive and growing by 40.4% per year.